Matthias Leisegang
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Selection of therapeutically effective T-cell receptors from the diverse tumor-bearing repertoire.
Journal: Journal for immunotherapy of cancer
Published: April 03, 2025
A CD22-specific T-cell receptor enables effective adoptive T-cell therapy for B-cell malignancies.
Journal: Blood
Published: March 25, 2025
A CD22-Specific T-Cell Receptor Enables Effective Adoptive T-Cell Therapy for B-cell malignancies.
Journal: Blood
Published: March 25, 2025
Generation of effective and specific human TCRs against tumor/testis antigen NY-ESO-1 in mice with humanized T cell recognition system.
Journal: Frontiers in immunology
Published: November 07, 2024
CD4+ T cells with convergent TCR recombination reprogram stroma and halt tumor progression in adoptive therapy.
Journal: Science immunology
Published: September 13, 2024
Oligonucleotide library screening for identification of virus-specific T-cell receptors.
Journal: European journal of immunology
Published: November 19, 2023
One CD4+TCR and One CD8+TCR Targeting Autochthonous Neoantigens Are Essential and Sufficient for Tumor Eradication.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: September 23, 2023
Identification of T Cell Receptors Targeting a Neoantigen Derived from Recurrently Mutated FGFR3.
Journal: Cancers
Published: December 05, 2022
ERAP2 supports TCR recognition of three immunotherapy targeted tumor epitopes.
Journal: Molecular immunology
Published: November 04, 2022
A systematic safety pipeline for selection of T-cell receptors to enter clinical use.
Journal: NPJ vaccines
Published: October 19, 2022
Last Updated: 09/26/2026